Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer

British Journal of Surgery

Volumn 88, Issue 8, 2001, Pages 1105-1109

  McDonnell, C O ^a   Harmey, J H ^b   Bouchier Hayes, D J ^b   Walsh, T N ^a  

^a Royal College of Surgeons in Ireland   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CISPLATIN; FLUOROURACIL; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HUMAN; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOTHELIAL GROWTH FACTORS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHOKINES; MALE; NEOVASCULARIZATION, PATHOLOGIC; PREOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034837802     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1323.2001.01838.x     Document Type: Article

References (31)

1. What is the evidence that tumors are angiogenesis dependent?
2. Angiogenesis in cancer, vascular, rheumatoid and other diseases
3. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
4. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
5. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
6. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients
7. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
8. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
9. TGF β-1 regulation of VEGF production by breast cancer cells
10. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression
11. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas
12. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
13. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma
14. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
15. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy
16. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions
17. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients
18. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
19. Circulating vascular endothelial growth factor in patients with colorectal cancer
20. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer
21. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer
22. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
23. Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients
24. Cytokine regulation of angiogenesis in breast cancer: The role of tumor-associated macrophages
25. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
26. Angiogenic effects of macrophages isolated from ascitic fluid aspirated from women with advanced ovarian cancer
27. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1
28. Blood flow influences vascular growth during tumour angiogenesis
29. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
30. Micrometastases in esophagogastric cancer: High detection rate in resected rib segments
31. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer